Literature DB >> 3320372

Mechanisms of association of Candida albicans with intestinal mucosa.

M J Kennedy1, P A Volz, C A Edwards, R J Yancey.   

Abstract

The association of Candida albicans with gastrointestinal (GI) mucosal surfaces was studied in vitro and in vivo. The caecal mucosal surfaces from antibiotic-treated and untreated control mice challenged orally with C. albicans revealed that large numbers of C. albicans were associated with the intestinal epithelium of antibiotic-treated mice but not with that of the control mice that possessed an indigenous wall-associated bacterial flora. Moreover, Candida cells only penetrated deep into the mucosa of animals in which the ecology of the intestinal microflora had been disrupted. In mice given antibiotics, C. albicans was associated with the mucosa of all areas of the GI tract; the caecal mucosa had the most associated Candida, whereas the stomach and small intestine had very few associated yeasts. Further examination of caecal mucosa from antibiotic-treated mice showed that C. albicans associated with the mucosa by at least five distinct mechanisms. These included: adhesion to epithelium, adhesion to mucus, co-adhesion to adherent fungi, co-adhesion to adherent bacteria, and entrapment in the mucous gel overlying the epithelium. The cell-surface hydrophobicity of C. albicans also was examined and found not to play a role in Candida adhesion to intestinal mucosa. The predominant association mechanisms appeared to be entrapment in the mucous gel, and adhesion to mucus and the epithelium. The ecological and pathological significance of co-adhesion by C. albicans to attached organisms is unclear but it may be important in the initiation of mucosal lesions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3320372     DOI: 10.1099/00222615-24-4-333

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  32 in total

1.  Esophageal Candida infection and adherence mechanisms in the nonimmunocompromised rabbit.

Authors:  K Hoshika; M Iida; H Mine
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

Review 2.  Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.

Authors:  David S Perlin
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

3.  Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.

Authors:  A R Colina; F Aumont; N Deslauriers; P Belhumeur; L de Repentigny
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Significance of modes of adherence in esophageal Candida albicans.

Authors:  K Hoshika; H Mine
Journal:  J Gastroenterol       Date:  1994-02       Impact factor: 7.527

Review 5.  Interactions of microorganisms with host mucins: a focus on Candida albicans.

Authors:  Ashley Valle Arevalo; Clarissa J Nobile
Journal:  FEMS Microbiol Rev       Date:  2020-09-01       Impact factor: 16.408

6.  Gastrointestinal colonization by Candida albicans mutant strains in antibiotic-treated mice.

Authors:  S M Wiesner; R P Jechorek; R M Garni; C M Bendel; C L Wells
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

7.  Role of yeast cell growth temperature on Candida albicans virulence in mice.

Authors:  P P Antley; K C Hazen
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

8.  In vitro inhibition of adhesion of Candida albicans clinical isolates to human buccal epithelial cells by Fuc alpha 1----2Gal beta-bearing complex carbohydrates.

Authors:  D Brassart; A Woltz; M Golliard; J R Neeser
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

9.  Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agents.

Authors:  G G Zhanel; J A Karlowsky; S A Zelenitsky; M A Turik; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

10.  Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans.

Authors:  G Samonis; A Gikas; E J Anaissie; G Vrenzos; S Maraki; Y Tselentis; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.